|
⚲
|
| Keyboard |
| AH Bio Fund I LP
✚
|
|
|---|---|
| CIK # | 0001656629 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001656629] | |
| 4 | [0001656629] | |
| D | [0001656629] | |
| SC 13D | [0001656629] | |
| SC 13G | [0001656629] |
| Form 13D/13G Filer | Form 13D/13G Subject | Filed |
|---|---|---|
| Ah Bio Fund I LP | Camp4 Therapeutics Corp | [2024-10-22] |
| Ah Bio Fund I LP | Bioage Labs Inc | [2024-10-04] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| AH Bio Fund I LP | |
| Camp4 Therapeutics Corp | |
| AH Equity Partners Bio I LLC | |
| Andreessen Marc L | |
| Horowitz Benjamin A | |
| AH Equity Partners Bio IV LLC | |
| AH Bio Fund IV LP |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Camp4 Therapeutics Corp CAMP
Common Stock
|
2024-10-15 | Buy | 181,818 | $11.00 | 1,999,998 |
|
Camp4 Therapeutics Corp CAMP
Common Stock
|
2024-10-15 | Buy | 545,454 | $11.00 | 5,999,994 |
|
Camp4 Therapeutics Corp CAMP
Common Stock
|
2024-10-15 | Conversion | 1,398,067 | ||
|
Camp4 Therapeutics Corp CAMP
Series A Prime Preferred Stock · derivative
|
2024-10-15 | Conversion | 15,001,312 | ||
|
Camp4 Therapeutics Corp CAMP
Series B Preferred Stock · derivative
|
2024-10-15 | Conversion | 679,163 |